Clinical Trials Sponsored by Via Christi Regional Medical Center-St Francis Campus
Total 0 results
Nothing found
Sponsors and Collaborators
- Fabian Rohner
- Shanghai IxCell Biotechnology Co., LTD
- José Castro
- GTEI
- Universität Tübingen
- Castleton University
- Bon Secours Pediatric Dental Associates
- MB Clinical Research, LLC
- Department of Cardiology, Lausanne University Center Hospital, Lausanne, Switzerland
- Damagen Genetic Diagnostic Center
- Junta de Andalucía - Consejería de Salud y Familias, Spain
- Mexican Emerging Infectious Diseases Clinical Research Network
- Crowley Carter Foundation
- Narhalsan primary care rehabilitation
- Don Cockcroft
- Hospital Sirio-Libanes Ensino e Pesquina
- Plymouth University Peninsula Schools of Medicine & Dentistry (PUPSMD)
- Belfast Arthroplasty Research Trust (BART)
- Biotics, Inc.
- University of Valladolid
- View Full List
Medical Conditions
- Support Program
- Prostate Specific Antigens
- Disturbance of Attention
- Rejection Acute Hepatic
- Confirmed Diagnosis of Cystic Fibrosis
- Nerve Entrapments
- Malignant Neoplasms of Female Genital Organs
- Tracheal Dilatation
- Retention of 3D Printed Dentures
- Opiate Dependent Patients Who Are Undergoing Inpatient Detoxification in Singapore
- Bulging of Vaginal Wall
- Genome-wide High Throughput Sequencing
- Vagus Nerve Injuries
- Unintentional Ingestion of Drugs Contained Within Prescription Vials and Blisters.
- Gastrointestinal Stromal Tumor of Stomach
- Diabetic Kidney Disease (DKD)
- Shared Decision Making
- To Contribute to a Better Control of COVID-19 in Children in Niger
- FLT3-ITD
- Multimodal Ultrasonographic Assessment of Axillary Lymph Nodes in Patients With Breast Cancer
- View Full List
Drug Interventions
- Metoprolol succinate sustained-release tablet
- Etanercept
- Lidocaine, epinephrine (Local anesthetic)
- Trimetazidine 35 mg
- Gliadel Wafer
- Axitinib plus toripalimab
- Fluorescein + ALA
- Sulfasalazine
- PF-05212384
- Fluorouracil
- Dapagliflozin
- Granulocyte colony-stimulating factor (G-CSF)
- ABT-199
- ATG-010 60 mg, orally, twice weekly, each 4 week (28-day) a cycle
- Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginase
- Azacitidine
- Cabozantinib
- PEP005 Gel
- SNAC
- Quadratus Lumborum Block type 2
- View Full List
CROs by country
- Contract Research Organizations in Armenia
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Burundi
- Contract Research Organizations in China
- Contract Research Organizations in Egypt
- Contract Research Organizations in France
- Contract Research Organizations in Gabon
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Malawi
- Contract Research Organizations in Serbia
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Tanzania
- CRO list by country